BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

983 related articles for article (PubMed ID: 30995872)

  • 1. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
    Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
    J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
    Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
    J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease.
    Zheng Z; Zhang S; Liu X; Wang X; Xue C; Wu X; Zhang X; Xu X; Liu Z; Yao L; Lu G
    J Cell Physiol; 2024 May; 239(5):e31250. PubMed ID: 38477420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.
    Cao B; Wang T; Qu Q; Kang T; Yang Q
    Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR‑185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson's disease.
    Wen Z; Zhang J; Tang P; Tu N; Wang K; Wu G
    Mol Med Rep; 2018 Jan; 17(1):131-137. PubMed ID: 29115479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease.
    Lv Q; Zhong Z; Hu B; Yan S; Yan Y; Zhang J; Shi T; Jiang L; Li W; Huang W
    J Neurochem; 2021 May; 157(3):599-610. PubMed ID: 33448372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
    Fan Y; Zhao X; Lu K; Cheng G
    Brain Res Bull; 2020 Apr; 157():119-127. PubMed ID: 32057951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
    Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease.
    Wang X; Liu Z; Wang F
    Neurochem Res; 2021 Jul; 46(7):1859-1868. PubMed ID: 33900518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
    Liu L; Zhou T; Li T; Liang Z; Luo X
    Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.
    Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H
    Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
    Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
    Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation.
    Hwang CJ; Lee HP; Choi DY; Jeong HS; Kim TH; Lee TH; Kim YM; Moon DB; Park SS; Kim SY; Oh KW; Hwang DY; Han SB; Lee HJ; Hong JT
    Oncotarget; 2016 Jul; 7(30):46943-46958. PubMed ID: 27409674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.